Clinical Trials Logo

Clinical Trial Summary

This study aims to evaluate the safety and immunogenicity of an inactivated cell culture derived H7N9 vaccine in healthy adult subjects.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT02436928
Study type Interventional
Source Medigen Vaccinology Corp.
Contact
Status Completed
Phase Phase 1/Phase 2
Start date April 2015
Completion date February 2016